# Resistance to the Tyrosine Kinase Inhibitor Osimertinib and Pharmacokinetics in Non-small Cell Lung Cancer

> **NCT05020275** · — · ACTIVE_NOT_RECRUITING · sponsor: **Rennes University Hospital** · enrollment: 60 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Blood Samples

## Key facts

- **NCT ID:** NCT05020275
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-29
- **Primary completion:** 2026-03-16
- **Final completion:** 2027-03-16
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05020275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05020275, "Resistance to the Tyrosine Kinase Inhibitor Osimertinib and Pharmacokinetics in Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05020275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*